Welcome to our dedicated page for Medirom Healthcare Technologies SEC filings (Ticker: MRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. MEDIROM files annual reports on Form 20-F and furnishes current and interim information on Form 6-K under the Securities Exchange Act of 1934. These documents offer detailed insight into the company’s relaxation salon operations, digital preventative healthcare activities, luxury beauty segment, and health-tech initiatives.
Form 6-K reports for MEDIROM frequently include press releases and explanatory notes about key corporate events. Recent examples cover the issuance and closing of Third Unsecured Convertible-Type Corporate Bonds with Share Options, including terms such as interest accrual, maturity dates, conversion options into common shares, and redemption provisions. Other 6-K filings furnish interim financial information, major Key Performance Indicators (KPIs), and updates on equity financing rounds at subsidiary MEDIROM MOTHER Labs Inc.
Through these filings, investors can review how MEDIROM structures its capital and financing, including unsecured short-term bank loans, convertible debt, and bond issuances conducted outside the United States under Regulation S. The filings also describe how proceeds are intended to be used for general corporate or financing purposes, subject to the company’s decisions over time.
Segment disclosures embedded in MEDIROM’s interim reports identify the Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty segments, along with revenue categories such as franchisor-owned outlets, franchise revenue, royalty revenue, sublease revenue, staffing service revenue, and other franchise-related income. These details help readers understand how the MEDIROM Group organizes its operations and reports performance across its salon network and health-tech businesses.
On Stock Titan, each newly furnished MEDIROM Form 6-K or other SEC document is made available with AI-powered summaries that highlight the most important points, such as financing terms, segment information, and material corporate announcements. Real-time updates from EDGAR ensure that filings related to topics like convertible bonds, treasury strategies involving digital assets, and subsidiary equity financings are accessible soon after publication. Users can quickly scan AI-generated explanations of lengthy reports, then open the full text for deeper review when needed.
For investors tracking MRM, this filings page is a central resource for reviewing MEDIROM’s official disclosures on capital structure, segment reporting, and material events as presented in its SEC submissions.
MEDIROM Healthcare Technologies Inc. (MRM) amendment updates beneficial ownership and related disclosures for CEO Kouji Eguchi and COZY LLC. Mr. Eguchi is reported to beneficially own 2,075,003 Common Shares, representing 25.77% of the class using an adjusted share base; COZY LLC beneficially owns 47,543 Common Shares (0.60%). The filing attributes the percentage change to the issuer issuing additional ADSs on December 11, 2024 rather than purchases by the reporting persons. The filing discloses that Mr. Eguchi holds stock options exercisable for 150,000 shares within 60 days and an additional 36,500 options subject to revenue targets. The amendment notes the joint filing, acquisitions by COZY since the original Schedule 13D, a transfer of 7,500 shares by Mr. Eguchi in June 2025, and that this Amendment No. 1 was filed late.
Healthcare Technologies Inc. submitted a Form 6-K to inform investors that it issued a press release on a regulatory milestone in Japan. The release explains that a product developed by its subsidiary, MOTHER Labs Inc., has received certification in connection with a governmental subsidy program in Japan. This type of certification can help support adoption of the product by making it eligible for public support, though specific financial terms are not described here. The full details are provided in the attached press release, which is included as Exhibit 99.1.
MEDIROM Healthcare Technologies Inc. submitted a Form 6-K reporting that it is issuing a press release about the expected introduction of a new technological device at certain relaxation salon locations and related plans regarding digital assets. The press release is furnished as Exhibit 99.1 and is provided for informational purposes under the Exchange Act, without being treated as filed for liability purposes or automatically incorporated into other securities law filings.
MEDIROM Healthcare Technologies Inc. furnished a Form 6-K to inform investors that it is issuing a press release with updated major key performance indicators (KPIs) for the month of July 2025. The press release, dated August 20, 2025, is attached as Exhibit 99.1.
The submission clarifies that the information in this report, including the exhibit, is furnished rather than filed and is not automatically incorporated by reference into other securities law filings unless specifically stated there.
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) submitted a routine Form 6-K on 20 June 2025. The filing simply furnishes—rather than files—a press release (Exhibit 99.1) that updates the Company’s Key Performance Indicators (KPIs) for May 2025. Because the information is “furnished,” it is not subject to Section 18 liability and will not be automatically incorporated by reference into other SEC documents. No financial statements, earnings results, or transaction details are included, and the Company confirms it continues to report under Form 20-F.